Highlights

  • 318,181,818 free attaching options proposed for placement participants.
  • 19,090,909 options proposed for the lead manager as a capital raising fee.
  • Options exercisable at A$0.004, expiring three years from issue.
  • Issue subject to shareholder approval on 30 November 2026.

Skin Elements Limited (ASX:SKN) has lodged an Appendix 3B outlining a proposed issue of two classes of unlisted options linked to a placement. The options are exercisable at A$0.004 each and expire three years after issue.

Details of the Proposed Options

The company proposes to issue 318,181,818 options as free attaching options, one for each placement share subscribed for. A further 19,090,909 options are proposed for the lead manager as a capital raising fee.

Each option will convert into one fully paid ordinary share. The placement shares themselves are covered by a separate Appendix 3B.

Lead Manager and Approvals

Phoenix Global Investments is lead manager and will receive a fee of 6% of gross proceeds, which it may take in cash or in shares and options on the same basis as the placement.

The issue requires shareholder approval, with the meeting date listed as 30 November 2026. If approved, the proposed issue date is 4 December 2026.

Use of Funds

According to the filing, the funds raised will support the advancement and commercialisation of the company's existing product programs.

These include the ECO Nurture plant bio-stimulant, SuprCuvr disinfectant, Soleo Organics sunscreen and the PapayaActivs therapeutic skincare and personal protection range.

Key Takeaways

  • Skin Elements plans to issue about 337 million unlisted options.
  • Most options are free attaching options for placement investors.
  • Shareholder approval is required on 30 November 2026.
  • Funds will support commercialisation of existing product lines.